Drug Marketing in China and Worldwide (October)(2023)
Drugs have been approved for marketing, and some diseases have been treated.
November 1, 2023
by PharmaSources
Pharmaceutical Business in China and Worldwide (September)(2023)
Pharmaceutical companies reached a cooperation agreement and began to commercialize drugs for the treatment of diseases.
October 1, 2023
by PharmaSources
Drug Marketing in China and Worldwide (August)(2023)
The official website shows that the drugs developed by major companies have been declared for marketing.
September 1, 2023
by PharmaSources
Pharmaceutical Business in China and Worldwide (July)
On July 11th, KELUN Biotech was officially listed on the Hong Kong Stock Exchange.
August 11, 2023
by Caicai/PharmaSources
Pharmaceutical Business Progress in China and Worldwide (March)
Progress in Pharmaceutical Business at Home and Abroad (March)
May 12, 2023
by PharmaSources
Weekly Pharma News Review | PharmaSources.com (1017-1021)
The news review of this week is from October 17 to 21, covering a total of 21 pieces of information in 3 sections, i.e., drug review, R&D, and listing.
October 24, 2022
by PharmaSources.com
Weekly Pharma News Review | PharmaSources.com (0919-0923)
The news reviewed this week is from September 19 to 23, covering a total of 25 pieces of information in 4 sections, i.e. drug review, R&D, and business and listing.
September 26, 2022
by PharmaSources.com
Weekly Pharma News Review | PharmaSources.com (0829-0902)
This week, the second biological drug developed by SinoCellTech - ripertamab, a new anti-CD20 monoclonal antibody, was approved for marketing, which aroused the attention of the industry. The news review of this week is from August 29 to September 2.
September 6, 2022
by PharmaSources.com
Weekly Pharma News Review | PharmaSources.com (April 11 to 15)
The sharp crushing in the stock prices of Chinese vaccine leader companies Zhifei Biological and Wantai Biological is the most-watched news this week.
April 20, 2022
by Yefenghong
Pharmaceutical News of the Week | CPhI.CN - Listing
Eyebright was successfully listed on the SSE STAR Market on July 29.
August 6, 2020
by PharmaSources/Caicai
Pharmaceutical News of the Week (June.15th-19th)| PharmaSources.com
With the third week of June coming to a close, let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions and listing that happened during June 15-19.
June 23, 2020
by PharmaSources/Caicai
Huakang Biomed declares first annual results since listing
Loss Reduced, profit before tax excluding listing expenses amounted to RMB9.1 Million; continuous focus on research and development; lying strong foundation for future growth
March 26, 2019
by biospectrumasia